Warren Buffett is reportedly eyeing Berkshire Hathaway’s biggest deal in three years

Warren Buffett is reportedly eyeing Berkshire Hathaway’s biggest deal in three years


In this article

  • BRK.B
  • OXY
Warren Buffett speaks during the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska, on May 3, 2025.
CNBC

Warren Buffett’s Berkshire Hathaway is closing in on a deal to buy Occidental Petroleum’s petrochemical unit OxyChem for roughly $10 billion, the Wall Street Journal reported Tuesday.

The potential deal, which could finalize within days per the Journal, could be Berkshire’s largest since 2022 when it bought insurer Alleghany for $11.6 billion. That deal was announced in March of that year and completed in October 2022. Berkshire is sitting on a record cash hoard of $344 billion.

Buffett, 95, is stepping down as Berkshire CEO at the end of 2025, but he will remain as chairman. Buffett’s successor Greg Abel, who was CEO of Berkshire Hathaway Energy, is known for his strong expertise in the energy industry.

Shares of Houston-based energy company fell 1.8% Tuesday despite WSJ’s report.

The Omaha-based conglomerate owned more than $11 billion worth of Occidental stock, or a 28.2% stake. The 95-year-old Buffett previously said he wouldn’t take full control of the oil company, founded by legendary oilman Armand Hammer.

In 2019, Buffett helped bankroll Occidental’s purchase of Anadarko Petroleum with a $10 billion commitment, receiving preferred shares and warrants to buy common stock in return. 

The billionaire investor started buying Occidental common stock in the open market in early 2022 after reading a transcript of the oil company’s earnings conference call. He took advantage of the heightened volatility in the Covid pandemic to scoop up the shares at a discount.

Occidental also pays a 2% dividend yield and has been investing in a carbon capture business.

— Click here to reach the original WSJ story.



Source

Stocks making the biggest moves midday: Fortinet, Moderna, Intel, Bausch Health & more
Finance

Stocks making the biggest moves midday: Fortinet, Moderna, Intel, Bausch Health & more

Check out the companies making headlines in midday trading. Fortinet — Shares jumped more than 7% after TD Cowen upgraded the cybersecurity stock to buy from hold, saying rising memory prices won’t hurt the company as much as some suspect. The firm’s $100 price target suggests 29% upside ahead. Bausch Health — The pharmaceutical stock […]

Read More
There’s a new idea of alpha in the market that big fund managers are pursuing
Finance

There’s a new idea of alpha in the market that big fund managers are pursuing

ETF Edge There’s a new idea of alpha in the market that big fund managers are pursuing Published Fri, Jan 23 202610:32 AM ESTUpdated 15 Min Ago Krysta Escobar Eric Rosenbaum@erprose WATCH LIVE Source

Read More
Stocks making the biggest moves premarket: Intel, Nvidia, Life360, Capital One & more
Finance

Stocks making the biggest moves premarket: Intel, Nvidia, Life360, Capital One & more

Check out the companies making headlines before the bell. Intel — Shares fell 13% after Intel reported mixed results for the fourth quarter, in addition to issuing softer guidance than expected for the current three-month period. The company posted 15 cents per share on an adjusted basis, topping analysts’ consensus estimate of 8 center per share, […]

Read More